Neo Ivy Capital Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-24
| Closed | -$1K | – | 547 |
|
|
2022
Q2 | $1K | Sell |
24
-2,256
| -99% | -$94K | ﹤0.01% | 378 |
|
|
2022
Q1 | $266K | Buy |
2,280
+1,691
| +287% | +$197K | 0.24% | 151 |
|
|
2021
Q4 | $89K | Buy |
589
+447
| +315% | +$67.5K | 0.13% | 230 |
|
|
2021
Q3 | $14K | Buy |
+142
| New | +$14K | 0.02% | 409 |
|
|
2021
Q2 | – | Sell |
-595
| Closed | -$53K | – | 611 |
|
|
2021
Q1 | $53K | Buy |
+595
| New | +$53K | 0.06% | 323 |
|
|
2020
Q3 | – | Sell |
-142
| Closed | -$14K | – | 620 |
|
|
2020
Q2 | $14K | Buy |
+142
| New | +$14K | 0.02% | 409 |
|
|
2019
Q4 | – | Sell |
-5,153
| Closed | -$373K | – | 392 |
|
|
2019
Q3 | $373K | Buy |
+5,153
| New | +$373K | 0.24% | 170 |
|
|
2019
Q2 | – | Sell |
-2,462
| Closed | -$156K | – | 403 |
|
|
2019
Q1 | $156K | Buy |
+2,462
| New | +$156K | 0.09% | 212 |
|